Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com
Equities researchers at StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 6.6 % Shares of NASDAQ AKTX opened at $0.99 on Friday. Akari Therapeutics has a twelve month […]
Equities researchers at StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 6.6 % Shares of NASDAQ AKTX opened at $0.99 on Friday. Akari Therapeutics has a twelve month […]
